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Highlights  
• 85% of infants carried pneumococcus at least once during the first year of 
life 
• Carriage duration longer for the first acquisition compared to subsequent 
episodes 
• Pneumococcal density is affected by antibiotic exposure and respiratory 
infection 
• Pneumococcal density decreases during a carriage episode 
• Most infants carried a single serotype at a time  
 
 
Abstract  
Objectives 
Nasopharyngeal carriage of Streptococcus pneumoniae underpins disease 
development and transmission. We examined pneumococcal carriage dynamics, 
including density and multiple serotype carriage, in Indonesian infants during the first 
year of life. 
Methods 
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200 healthy infants were enrolled at 2 months of age, with 8 nasopharyngeal swabs 
collected from enrolment until 12 months of age. Pneumococci were detected using 
quantitative PCR and serotyped by microarray. Regression models assessed factors 
influencing pneumococcal carriage and density. 
Results 
85% of infants carried pneumococci at least once during the study. The median age 
of first acquisition was 129 days (IQR 41, 216). The median duration of carriage was 
longer for the first pneumococcal acquisition compared with subsequent acquisitions 
(151 days vs 95 days, p < 0.0001). Of 166 infants who carried pneumococci during 
the study, the majority (63.9%) carried a single pneumococcal serotype at a time. 
Pneumococcal carriage density was higher when upper respiratory tract infection 
symptoms were present, lower during antibiotic usage, decreased with age, and 
tended to decrease over time during a carriage episode.  
Conclusions 
The majority of Indonesian infants carry pneumococcus at least once during the first 
year of life. Pneumococcal carriage is a dynamic process, with pneumococcal 
density varying during a carriage episode. 
 
Keywords: Streptococcus pneumoniae, pneumococcus, nasopharynx, bacterial 
carriage, serotypes 
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Introduction 
Streptococcus pneumoniae (pneumococcus) can cause a variety of diseases 
ranging from otitis media to pneumonia, meningitis, and sepsis, and was responsible 
for an estimated 317,300 pediatric deaths in 2015.[1] Pneumococci commonly 
colonize the nasopharynx of young children, with carriage prevalence ranging from 
19 – 86%.[2] Carriage is considered an essential first step in the development of 
pneumococcal disease, and is the source of transmission within human 
populations.[3] Pneumococcal conjugate vaccines (PCVs) reduce carriage by 
blocking the acquisition of vaccine-serotype pneumococci, protecting immunized 
children and resulting in potent indirect effects by reducing transmission to 
unvaccinated individuals.[4]  
Data from longitudinal studies demonstrate that carriage is a dynamic process. The 
timing of acquisition and clearance is influenced by factors including serotype, age, 
and previous pneumococcal exposure.[5-7] Young children commonly experience 
multiple carriage episodes: a study in Thailand reported a median of 7 
pneumococcal acquisitions during the first 24 months of life.[6] High pneumococcal 
density in the nasopharynx is associated with pneumonia in children, and linked to 
transmission in animal studies.[8, 9] Simultaneous carriage of multiple 
pneumococcal serotypes is common in children in low- and middle-income 
countries.[10] Few published longitudinal carriage studies to date examined 
pneumococcal density or used methods capable of detecting multiple serotype 
carriage. A detailed investigation of carriage dynamics, including quantitative 
information on pneumococcal density and detection of co-colonizing serotypes, 
would improve our understanding of this important process, and provide useful 
information for estimating and evaluating vaccine effects.  
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We conducted a longitudinal study in Indonesia, a country with no national PCV 
program, to examine pneumococcal carriage during the first year of life. Indonesia 
has a high burden of childhood pneumonia, which is the leading cause of death in 
children outside the neonatal period, with an estimated incidence of 326 per 1000 
children per year in 2015. [11,12] Previous studies have reported pneumococcal 
carriage prevalence ranging from 43% - 53% in young children in Indonesia.[13-16] 
The study aim was to determine pneumococcal carriage prevalence and density over 
time, and investigate the dynamics of carriage, including acquisition, duration, and 
multiple serotype carriage, using quantitative molecular methods.  
Methods 
Study population, design, and procedures 
This study was conducted in the Bandung region of West Java, Indonesia. Indonesia 
is a lower-middle-income country consisting of over 17,000 islands, with a population 
of over 260 million. The estimated case rate of pneumonia in Indonesian children is 
approximately 5,000 per 100,000 hospital discharges.[17] Childhood mortality varies 
regionally and between urban and rural settings.[18] Indonesian infants routinely 
receive BCG, polio, HepB (birth dose), pentavalent (DTP-HepB-Hib), and measles- 
rubella vaccination as part the Expanded Program on Immunization.  
Recruitment was conducted at two health centers, an urban center in Bandung city 
and a semi-rural center located in the Padalarang district approximately 25 km from 
Bandung city, from November 2014 – January 2015. Mothers of newborns were 
identified by community health workers and invited to have their infant participate in 
the study. Written informed consent was obtained from a parent/guardian prior to any 
study procedures. Enrolment criteria included age of 8 – 12 weeks, weight >2500 g, 
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living within the study area and no plans to relocate during the follow-up period, and 
judged in good health following examination by a pediatrician. Exclusion criteria 
included moderate/severe illness at the time of screening, axillary temperature ≥ 
38°C, antibiotic use within the previous 14 days, prior hospitalization for conditions 
excluding jaundice, mother with known HIV positive status, and prior or expected 
PCV immunization. 
Data on demographics and household information were collected by study staff at 
the initial visit. Six subsequent visits were conducted monthly, then a final visit at 12 
months of age. Data on upper respiratory tract infection (URTI) symptoms 
(rhinorrhea, cough, or other respiratory symptoms), recent antibiotic usage, breast 
feeding status, and major illnesses/hospitalizations were collected at follow-up visits. 
At each visit, a nasopharyngeal swab was collected according to World Health 
Organization recommendations.[19]  
The sample size was based on an estimated pneumococcal carriage prevalence of 
50% at 5 months of age.[13] 120 participants would estimate carriage prevalence 
with confidence intervals of ± 8.9%. The sample size was increased to 200 to 
facilitate secondary analyses.  
Ethics approval was granted from the Health Research Ethics Committee, 
Universitas Padjadaran Faculty of Medicine, Indonesia 
(536/UN6.C2.1.2/KEPK/PN/2014) and the Royal Children’s Hospital Human 
Research Ethics Committee, Australia (34124). 
Laboratory analyses 
Swabs were placed into 1 ml skim milk tryptone glucose glycerol (STGG) medium, 
kept in a cool box, and transported to the Microbiology Laboratory at the Advanced 
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Biomedical Laboratory, Faculty of Medicine, Universitas Padjadaran, Bandung for 
aliquotting and storage at -70°C within 8 hours of collection. Pneumococci were 
detected and serotyped as previously described.[16] In brief, DNA extracted from 
STGG was examined by lytA real-time quantitative PCR (qPCR) to detect 
pneumococci and determine pneumococcal density, reported in genome 
equivalents/ml (GE/ml).[20] Molecular serotyping by microarray was conducted 
following a culture-amplification step, in which 50 µl of the neat sample and a 1:10 
dilution were plated on selective agar and incubated overnight. The plate containing 
optimal growth of high-density, distinct colonies was selected for DNA extraction. 
DNA was fragmented, fluorescently labeled, and microarray conducted using Senti-
SP v1.6 (BUGS Bioscience), which reports the identity and relative abundance (%) 
of all serotypes present within a sample.[10] Previously, this method was found to 
have very high sensitivity, including >93% sensitivity for the detection of secondary 
serotypes present in low proportion in samples containing multiple serotypes [10]. 
Serotype-specific density was determined by multiplying pneumococcal density 
(determined by qPCR) by the serotype relative abundance (determined by 
microarray). A representative isolate from each sample was serotyped by latex 
agglutination/Quellung.  
Data analysis 
Definitions of pneumococcal carriage episodes were based on identification of an 
individual serotype, and estimates of dates of acquisition (midpoint between last 
negative swab and first positive swab) and clearance (midpoint between last positive 
swab and subsequent negative swab) were consistent with published longitudinal 
carriage studies.[6, 21-23] For infants carrying pneumococci at enrolment, the date 
of acquisition was estimated as the midpoint between birth and visit 1. Clinical data 
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were entered into a database (dBASE software, dBase LLC, Binghamton, NY, USA) 
then merged with laboratory data and cleaned using Stata version 14.2 (StataCorp, 
College Station, TX, USA). Statistical analyses were conducted using Stata and 
GraphPad Prism version 7.03 (GraphPad Software, La Jolla, CA, USA). 
Pneumococcal density data were log10 transformed prior to analysis. The Chi-
squared test was used to compare categorical data and t-test or ANOVA for 
continuous data unless otherwise noted. Data on carriage prevalence, age at first 
acquisition, and number of acquisitions were examined overall and by residence type 
(urban vs semi-rural). All other analyses used overall data. Kaplan-Meier curves 
were used to examine time to first pneumococcal acquisition and the log-rank test to 
compare by residence type. Multivariable Cox regression analysis was used to 
assess whether the following factors were associated with time (in days) to first 
acquisition: residence type, ethnicity, two or more children <5 years of age in the 
household, cigarette smoker in the household, breast feeding, parental income, and 
maternal education. Parametric survival models (Weibull distribution) were used to 
assess carriage duration; carriage episodes that were ongoing at the final study visit 
were censored. Carriage episodes that were first detected at the final study visit 
were excluded from analyses of carriage duration. The log-rank test was used to 
compare carriage duration for first vs. subsequent acquisitions.  
Logistic regression models were used to evaluate relationships between age 
(months), antibiotic exposure and presence of URTI symptoms (variables selected a 
priori) and pneumococcal carriage, incorporating Generalized Estimating Equations 
(GEEs) with robust 95% CIs and unstructured working correlation matrix to account 
for repeated sampling of individuals. GEE linear regression models were used to 
investigate associations between overall pneumococcal density and age, antibiotic 
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exposure, URTI symptoms, and multiple serotype carriage. For longer carriage 
episodes (serotype detected in ≥ 3 swabs), the detection stages of carriage episode 
were defined as initial (first detection), middle (subsequent detections), and final (last 
detection prior to clearance). To examine associations between stage of carriage 
episode and serotype-specific density, a 3-level linear random intercept model was 
used, with repeated density measures nested within serotypes and multiple 
serotypes nested within individuals (to account for repeated sampling and multiple 
serotype carriage). Covariates in the model included and age, antibiotic exposure, 
URTI symptoms, and multiple serotype carriage. 
Dynamics of pneumococcal carriage were categorized into five observed patterns: 
‘single serotype carriage’ (carriage of a single serotype at a time), ‘serotype 
replacement’ (an initial colonizing serotype became outnumbered by a newly 
acquired serotype and was subsequently cleared), ‘serotype dominance’ (carriage of 
an initial colonizing serotype was maintained and newly acquired serotypes were 
transient), ‘stable co-colonization’ (two serotypes simultaneously carried across 
multiple time points, and ‘short term co-colonization’ (multiple serotype carriage 
observed at a single time point).  
Results 
A total of 200 infants were enrolled in the study, with participant characteristics 
shown in Table 1. During the study period, there was one participant death 
(respiratory failure due to severe bronchopneumonia plus suspected congenital 
rubella syndrome) and two drop-outs, and three participants missed swab collection 
visits. Eight participants were hospitalized with a diagnosis of pneumonia. 
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A total of 1575 nasopharyngeal swabs were collected. Four swabs were excluded 
due to technical issues. The overall pneumococcal carriage prevalence was 22.0% 
(44/200; 95%CI 16.5 – 28.4) at enrolment and increased to 68.4% (62/196; 95%CI 
61.4 – 74.8) at 12 months of age. Pneumococcal carriage rates are shown by site 
and age in Figure 1. At 2 and 7 months of age, pneumococcal carriage prevalence 
was higher in semi-rural infants compared with those from urban areas (p = 0.01 and 
p = 0.045, respectively).  
Most (169/198, 85.4%) of infants carried pneumococci at least once during the study 
period. The median age of first acquisition was 129 days (IQR 41, 216). Figure 2 
depicts time to first pneumococcal acquisition for urban and semi-rural infants (p = 
0.064). None of the potential risk factors evaluated were associated with time to first 
acquisition, however there was some evidence that higher parental income was 
associated with delayed first acquisition (p = 0.055, Supplementary Table 1). The 
number of pneumococcal acquisitions per child during the study period ranged from 
0 to 5, with a median of 1 (IQR 1, 2) overall, 1 for urban infants (IQR 1, 2), and 2 
(IQR 1, 3) for semi-rural infants (p = 0.061, Mann-Whitney test). A total of 318 
pneumococcal acquisitions occurred during 70,429 days at risk, an acquisition rate 
of 0.0045 per day (95%CI 0.0040, 0.0050), or 0.14 per month (95%CI 0.12, 0.15).  
Antibiotic usage during the study period was reported at least once for 54/198 
(27.3%) of study participants. Thirty-seven swabs were collected from infants 
currently taking oral antibiotics (13 of which [35%] were positive for pneumococcus), 
and an additional 17 infants took antibiotics within 14 days of swab collection. 
Overall, 170 (85.6%) study participants had URTI symptoms during at least one 
study visit, and 364 (23.1%) of swabs were collected from infants with current URTI 
symptoms. Current or recent antibiotic usage was negatively associated with 
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pneumococcal carriage whereas presence of URTI symptoms was positively 
associated (Table 2).  
Pneumococci identified during the study period belonged to 46 capsular serotypes 
and 4 genetic variants of non-encapsulated pneumococci.[24] Thirty of 650 (4.6%) 
lytA-positive samples were culture negative and therefore not serotyped. Serotypes 
6B, NT2 (a non-encapsulated lineage), 19F, 23F, 34, and 15B/C were the most 
common (Figure 3). All serotype 11A pneumococci identified were typed as 11F-like 
variants by microarray.[25] 122 (38.4%) of carriage episodes were due to serotypes 
included in PCV13. The carriage prevalence of PCV13 serotypes, non-PCV13 
serotypes, and non-encapsulated pneumococci over time is shown in Supplementary 
Figure 1. Carriage prevalence of PCV13 serotypes increased from 9.1% at 
enrolment to 35.1% at 12 months. 
Overall, the median duration of carriage was 132 days (IQR 77, 217), ranging from 
28 to 328 days. Four infants carried the same pneumococcal serotype for the entire 
study duration. The median carriage duration for the first pneumococcal acquisition 
was 158 days (IQR 84, 260), compared with 95 days (IQR 56, 161) for subsequent 
acquisitions (p = 0.0013, log-rank test). Pneumococcal density ranged from 2.33 to 
8.76 log10 GE/ml, with a mean of 6.04 log10 GE/ml (95%CI 5.96, 6.11). 
Pneumococcal density is shown by age and site in Supplementary Figure 2. Density 
did not differ by site (p = 0.694, t-test) and there was some evidence that density 
differed by age (p = 0.066, one-way ANOVA). Regression analysis demonstrated 
that in pneumococcal carriers, density was higher when URTI symptoms were 
present and decreased with age, and there was some evidence that density was 
lower in infants currently on antibiotics (Table 3). 
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Multiple serotype carriage was observed in 98 samples (two serotypes n = 93, three 
serotypes n = 5), and increased with age (Supplementary Figure 1). Fifty-nine of 198 
(29.8%) participants had multiple serotype carriage observed at least once.  Multiple 
serotype carriage was associated with higher overall pneumococcal density (Table 
3). During longer carriage episodes (defined as detected in ≥ 3 swabs), serotype-
specific density tended to decrease over time, with mean density higher at initial 
detection (6.36 log10 GE/ml [95%CI 6.18, 6.53]) compared with the final detection 
prior to clearance (5.71 log10 GE/ml [95%CI 5.47, 5.95] (Figure 4). In a multi-level 
model including URTI symptoms, antibiotic use, multiple serotype carriage, and age, 
density at final detection was 0.62 log10 GE/ml lower at final detection compared with 
initial detection (Table 4).  
We examined carriage dynamics of the 166 participants who carried pneumococci at 
least once after excluding three with no serotyping data. A representative example of 
each pattern is shown in Figure 5. Single serotype carriage was the most common (n 
= 106, 63.9%), followed by serotype replacement (n = 11, 6.6%) and serotype 
dominance (n = 10, 6.0%).  Stable co-colonization and short term co-colonization 
were each observed in 8 (4.8%) participants. For 23 (13.8%) participants, no pattern 
was determined as multiple serotype carriage was only observed at the final swab 
collection. 
Discussion 
At 12 months of age, 68% of Indonesian infants carried pneumococcus, with a 
median age of acquisition at 129 days. These findings reflect of a setting of 
moderate pneumococcal carriage intensity in comparison to longitudinal studies 
conducted in other areas. In Finland, carriage prevalence peaked at 28% at 18 
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months of age, and in the US, the mean age of acquisition was six months.[26,27] In 
high carriage intensity settings such as The Gambia, Kenya, South Africa, Malawi, 
and a refugee camp in Thailand, median age at first pneumococcal acquisition 
ranged from 33 to 63 days.[5, 6, 21-23] In these settings, pneumococcal carriage 
prevalence peaked by six months, for example reaching 64% in South Africa and 
80% in Thailand, whereas in Indonesia carriage prevalence continued to rise until 12 
months of age.[6, 22] We previously reported a pneumococcal carriage prevalence 
of 64% in children aged 12-24 month olds in the Bandung region, suggesting that 
carriage rates stabilize after 12 months in this population.[16] Carriage prevalence 
tended to be higher in infants living in semi-rural areas than urban residents as 
observed in some, but not all, other studies.[28,29] Previously, we did not observe 
differences in pneumococcal carriage between urban and semi-rural Indonesian 
children aged 12-24 months, suggesting that differences diminish with age.[30]  
Data from Indonesia could inform models for pneumococcal vaccine trials in similar 
settings, particularly in Asia, where PCV introduction has lagged behind compared to 
other regions.[31,32]  Data on serotypes causing invasive pneumococcal disease in 
Indonesia are extremely limited, a major knowledge gap for this country. We 
therefore were not able to correlate carriage data with serotypes causing disease. 
Modeling approaches have used carriage data to predict serotypes causing invasive 
disease and vaccine impact and may be an avenue for future investigation.[33,34] 
We found that duration of carriage was longer for initial pneumococcal acquisitions 
compared to subsequent acquisitions, regardless of serotype. Although maturation of 
the immune system with age likely contributes to this effect, it is recognized that 
pneumococcal colonization is immunizing.[35] Epidemiologic evidence suggests that 
both serotype-specific and serotype-independent immunity are generated by 
AC
CE
PT
ED
MA
NU
SC
RI
PT
 14 
 
pneumococcal carriage. In Bangladesh, acquisition rates of the four most common 
serotypes were lower in children who had previously experienced carriage of a 
heterologous serotype, suggestive of serotype-independent immunity.[36] In 
Thailand, the interval to reacquisition of common serotypes was longer in children 
who had previously carried either homologous or heterologous serotypes, and 
carriage duration of serotypes 14 and 19F was shorter when reacquired following 
homologous carriage.[6] Serotype 6B, which was the most commonly acquired 
serotype in the current study, was not among the ten most common serotypes 
carried by children aged 12-24 months in Bandung, suggesting that carriage of 
serotype 6B during infancy may generate a serotype-specific immune response that 
is protective in later childhood.[16] A study in Israeli toddlers found that children who 
previously carried serotypes 14 and 23F had a reduced risk of subsequent carriage 
of those serotypes, and protection correlated with increased levels of serotype-
specific antibodies.[37] Further investigation of the immune responses induced by 
carriage, particularly those that contribute to serotype-independent immunity, could 
help in the design of non-capsular pneumococcal vaccines.  
High pneumococcal density in the nasopharynx has been linked to pneumococcal 
pneumonia and invasive pneumococcal disease, and investigated as a potential 
diagnostic tool.[38,39] Our study provides new insights into pneumococcal density 
during a carriage episode, highlighting the fact that carriage is a dynamic process, 
affected by multiple factors including antibiotic exposure and URTIs, as well as the 
presence of co-colonizing pneumococcal serotypes. We found that multiple serotype 
carriage was associated with higher overall pneumococcal carriage density by lytA 
qPCR, but lower serotype-specific density in comparison to carriage of a single 
pneumococcal serotype.  
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We demonstrated that density during longer carriage episodes tends to decrease 
over time. This observation is consistent with a mouse model of pneumococcal 
carriage, in which mice inoculated with a high dose of pneumococci display 
decreasing pneumococcal density in the nasopharynx prior to clearance.[40] 
Bacterial characteristics may also affect colonization density: a cross-sectional study 
reported that pneumococcal density varies by serotype.[41] However, studies that 
rely on a single sample to evaluate pneumococcal density should be aware of the 
limitations of that approach, particularly if they do not adjust for potential 
confounding.  
The main limitation to our study was the sampling time frame, with monthly intervals 
between swab collection, and a ~4 month gap prior to collection of the final swab at 
12 months of age. Short carriage episodes that occurred between sampling points 
would not have been detected, so pneumococcal acquisition was likely 
underestimated. As the first swab was collected at two months of age, we were 
unable to determine an accurate date of acquisition for the 44 participants who 
carried pneumococcus at enrolment. Longitudinal carriage studies conducted in The 
Gambia and South Africa collected swabs at birth and twice a month thereafter, and 
are therefore a better source of data on pneumococcal carriage in early 
infancy.[5,22] 
Wider sampling time frames bias estimates of carriage duration upwards, so this 
may in part explain why the median carriage duration in our study (131 days) was 
longer than those reported in studies with more frequent sampling from The Gambia 
(84 days), Kenya (31 days), Thailand (31 days), and South Africa (30 days).[5-7, 22] 
The ability of our methods to detect secondary serotypes present in lower 
abundance (as opposed to conventional methods that typically detect a single 
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serotype per sample) would have increased the sensitivity of detection and also 
contributed to longer estimates of carriage duration. We did not evaluate serotype-
specific differences in carriage duration due to small numbers, however differences 
have been reported in studies from Thailand and The Gambia.[5,6] Serotype, 
antimicrobial resistance, and prophage were found to be associated with carriage 
duration in a large pneumococcal genomics study.[42] 
We did not conduct testing of viruses or detection of other colonizing bacteria such 
as Haemophilus influenzae that can influence the density and dynamics of 
pneumococcal carriage.[16, 43,44] The positive association between URTI 
symptoms and pneumococcal carriage rates and density observed in our study is 
consistent with several studies reporting increased pneumococcal density during 
viral URTIs.[8, 45] In children under three years old in rural Peru, pneumococcal 
densities peaked during acute respiratory illness and were higher in children who 
tested positive for a respiratory virus, particularly rhinovirus, compared to those who 
were virus-negative.[46] Interestingly, DeMuri et al. recently demonstrated that 
pneumococcal densities were higher in American children aged 4 – 7 when a 
respiratory virus was detected, regardless of whether the children displayed URTI 
symptoms.[47] HIV status was not determined for mothers or infants in our study, but 
as the prevalence of HIV in the general population of Indonesia is estimated to be 
<0.5%, we assume a similar low rate amongst participants.[48] 
The laboratory methods utilized in our study enabled discrimination of different 
pneumococcal colonization patterns. Carriage of a single serotype at a time was 
most common, in line with epidemiologic data and a mouse model indicating that 
pneumococcal carriage inhibits acquisition of a second pneumococcal strain.[49,50] 
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Recently, the competitive advantage of an established pneumococcal strain against 
newcomers was found to be dependent on the quorum sensing system.[51] 
Within-host serotype replacement was observed; this may be due to an immune-
mediated reduction in density of the original colonizing serotype that facilitates 
expansion of a more recently acquired serotype and/or direct competition between 
pneumococcal strains, which has been observed in experimental models.[52,53]  
As multiple serotype carriage was highest at 12 months in our study, it would be 
interesting to examine co-colonization dynamics in slightly older children. Larger 
sample sizes would be required to examine the role of serotype in co-colonization 
dynamics.  
Our study provides useful data on pneumococcal carriage during infancy in 
Indonesia, with relevance to other moderate-intensity carriage settings. Better 
understanding of how the natural history of pneumococcal colonization affects 
subsequent pneumococcal carriage episodes may help develop vaccines that can 
harness the immunizing effects of colonization, and also improve mathematical 
models of pneumococcal carriage. Our findings highlight the dynamic nature of 
pneumococcal carriage, particularly the changes in pneumococcal density that can 
occur during a carriage episode.  
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Figure Captions 
Figure 1. Pneumococcal carriage prevalence by age for infants living in urban and 
semi-rural areas. Bars indicate ± 95%CI. * P < 0.05, chi-squared test. 
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Figure 2. Age (in days) at first pneumococcal acquisition for infants living in urban 
and semi-rural areas. P = 0.064, log-rank test. 
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Figure 3. Pneumococcal carriage episodes by serotype. PCV13 serotypes are 
shown in red (* indicates the three serotypes not included in PCV10), non-PCV13 
capsular serotypes are shown in black, and non-encapsulated pneumococci 
(categorized into genetic variants [22]) are shown in grey. ‘Other PCV13’ consists of 
serotypes 1 and 7F (n = 2, each). ‘Other NVT’ consists of serotypes 8, 45, 17F, 23B 
(n = 3 each), 38, 39, 18A, 19B, 28F, 35F, 7C (n = 2 each), and 40, 10F, 12F, 15F, 
17A, and 28A (n = 1 each). ‘Other NESp’ consists of non-encapsulated lineages 
NT4b (n = 2) and NT2/NT3b (n = 1).  
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Figure 4. Serotype-specific pneumococcal carriage density (in log10 genome 
equivalents/ml) shown by stage of carriage episode, for episodes that were detected 
in ≥ 3 swabs. Detection stages defined as initial detection, middle (subsequent 
detections), and final (last detection prior to clearance). Bars indicate mean ± 95% 
CI. p < 0.0001, one-way ANOVA. 
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Figure 5. Patterns of pneumococcal carriage dynamics. Representative examples, 
each from an individual study participant, are shown for the following patterns: A. 
Single serotype carriage; B. Short-term co-colonization; C. Serotype replacement; D. 
Serotype dominance; E. Stable co-colonization. Serotype-specific pneumococcal 
carriage density (in log10 genome equivalents/ml) is shown over time. Serotypes are 
labelled on the graph, with the first acquisition shown in pink, second acquisition in 
green, third in light blue, and fourth in navy.  
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Tables 
Table 1. Characteristics of study participants at enrolment. 
Characteristic Total  
(n = 200) 
N (%) 
Urban 
(n = 98)  
N (%) 
Semi-rural 
(n = 102) 
N (%) 
Sex  
 Male 115 (57.5) 64 (65)  51 (50) 
 Female 85 (42.5) 34 (35) 51 (50) 
Age (months) 
 Median (IQR2) 2.1 (2.0, 2.3) 2.0 (2.0, 2.2) 2.2 (2.0, 2.5) 
Weight (kg) 
 Median (IQR) 5.2 (4.8, 5.8) 5.2 (4.8, 5.8) 5.2 (4.8, 5.8) 
Height (cm)  
 Median (IQR) 58 (57, 60) 58 (56, 60) 58 (57, 59) 
Weight-for-length Z score 
 Median (IQR) -0.4 (-1.2, 0.2) -0.4 (-1.2, 0.1) -0.4 (-1.2, 0.4) 
Ethnicity 
 Sundanese  162 (81.0) 68 (69) 94 (92) 
 Javanese 35 (17.5) 29 (30) 6 (6) 
 Other 3 (1.5) 1 (1) 2 (2) 
Paternal education 
 Elementary school 23 (11.5) 6 (6) 17 (17) 
 Junior high school 53 (26.5) 16 (16) 37 (37) 
 Senior high school 99 (49.5) 59 (60) 40 (39) 
 University 25 (12.5) 17 (17) 8 (8) 
Maternal education 
 None 1 (0.5) 1 (1) 0 (0) 
 Elementary school 23 (11.5) 4 (4) 19 (19) 
 Junior high school 51 (25.5) 15 (15) 36 (35) 
 Senior high school 105 (52.5) 66 (67) 39 (38) 
 University 20 (10.0) 12 (12) 8 (8) 
Parental monthly income 
 Declined to answer 2 (1.0) 1 (1) 1 (1) 
 ≤ Regional minimum 
salary3 
159 (79.5) 73 (74) 86 (84) 
 > Regional minimum 
salary 
39 (19.5) 24 (24) 15 (15) 
Number of children < 5y in the household 
 1 109 (54.5) 39 (39) 70 (69) 
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 2 64 (32.0) 39 (39) 25 (24) 
 3 18 (9.0) 13 (13) 5 (5) 
 4 9 (4.5) 7 (7) 2 (2) 
Cigarette smoker in the household 
 No 57 (28.5) 36 (37) 21 (21) 
 Yes 143 (71.5) 62 (63) 81 (79) 
Breast feeding at 12 months 
 No 19/198 (9.6) 9/96 (9) 10/102 (9.8) 
 Yes 179/198 (90.4) 87/91 (94) 92/102 (90.2) 
1Chi-squared test for categorical values, Mann-Whitney test for age, t-test for weight 
and height. 
2IQR= interquartile range 
3Regional minimum salary rates for 2014 were 2,000,000 IDR/month for urban and 
1,738,476 IDR/month for semi-rural participants.  
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Table 2. Logistic regression analysis of factors associated with pneumococcal 
carriage in Indonesian infants during the first year of life. Models incorporate 
Generalized Estimating Equations to account for repeated sampling. (n = 1,571) 
 OR (95%CI)1 P value Adjusted OR 
(95%CI) 
P value 
Antibiotic 
exposure2 
0.53 (0.33, 0.85) 0.009 0.44 (0.25, 0.78) 0.004 
URTI symptoms 1.25 (1.06, 1.48) 0.010 1.21 (1.01, 1.46) 0.041 
Age (months) 1.21 (1.17, 1.26) <0.001 1.22 (1.17, 1.27) <0.001 
1OR = odds ratio 
2current and/or within the previous 14 days 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
 33 
 
Table 3. Linear regression analysis of factors associated with pneumococcal 
carriage density in pneumococcal-positive samples (n = 680). Models incorporate 
Generalized Estimating Equations to account for repeated sampling.  
 Unadjusted 
coefficient 
(95%CI)1 
P value Adjusted 
coefficient  
(95%CI) 
P value 
Current antibiotic 
use2 
-0.56 (-1.07, -0.05) 0.031 -0.74 (-1.51, 0.03) 0.059 
URTI symptoms 0.27 (0.10, 0.44) 0.002 0.31 (0.15, 0.46) <0.001 
Age (months) -0.03 (-0.06, -0.01) 0.010 -0.04 (-0.06, -0.01) 0.005 
Multiple serotype 
carriage 
0.18 (0.00, 0.37)  0.051 0.26 (0.06, 0.46) 0.011 
1Coefficient is the difference in means (log10 genome equivalents/ml). For example, 
infants on antibiotics at the time of swabbing had a mean pneumococcal density 0.56 
log10 lower than those not currently using antibiotics, whereas infants with URTI 
symptoms had a mean pneumococcal density 0.27 log10 higher than those without 
URTI symptoms. For each month increase in age, the mean pneumococcal density 
decreased by 0.03 log10. 
2Antibiotic use at the time of swabbing. 
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Table 4. Multivariable analysis of serotype-specific pneumococcal density during 
longer carriage episodes (detected in ≥ 3 swabs). The three-level model accounts for 
repeated sampling and multiple serotype carriage, and included detection stage, 
age, antibiotic exposure, URTI symptoms, and multiple serotype carriage. (n = 364)  
 Unadjusted 
coefficient 
(95%CI)1 
P value Adjusted 
coefficient  
(95%CI) 
P value 
Stage of carriage episode    
  Initial 
  Middle  
  Final 
reference 
-0.36 (-0.59, -0.13) 
-0.65 (-0.92, -0.38) 
  
 0.002 
 <0.001 
reference 
-0.35 (-0.60, -0.09) 
-0.62 (-0.99, -0.25) 
 
 0.008 
 0.001 
URTI symptoms 0.06 (-0.16, 0.28)  0.594 0.18 (-0.04, 0.40)  0.106 
Current antibiotic 
use2 
-0.90 (-1.65, -0.15)  0.019 -0.96 (-1.70, -0.23)  0.010 
Multiple serotype 
carriage 
-0.30 (-0.56, -0.05)  0.020 -0.27 (-0.53, -0.02)  0.033 
Age (months) -0.09 (-0.14, -0.04)  0.001 -0.01 (-0.09, 0.07)  0.792 
1Coefficient is the difference in means (log10 genome equivalents /ml). See Table 3 
footnote for further information on how to interpret the coefficient. 
2Antibiotic use at the time of swabbing. 
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